NCT02670395View on ClinicalTrials.gov

A Study to Investigate the Safety, Tolerability, Food Effect, and Pharmacokinetics of JNJ-54416076 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions
Healthy
Interventions
DRUG

JNJ-54416076

JNJ-54416076 suspension will be administered orally.

DRUG

Placebo

Placebo solution will be administered orally.

Trial Locations (1)

Unknown

Neuss

All Listed Sponsors
lead

Janssen Research & Development, LLC

INDUSTRY

NCT02670395 - A Study to Investigate the Safety, Tolerability, Food Effect, and Pharmacokinetics of JNJ-54416076 in Healthy Participants | Biotech Hunter | Biotech Hunter